Pregabalin attenuates dysautonomia as well as painful dysesthesia caused by Guillain–Barré syndrome
Clinical and Experimental Neuroimmunology · 2013
DOI: 10.1111/cen3.12006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Experimental Neuroimmunology, 2013. Verfasst von Hiroshi Kuroda und 7 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 8 Literaturangaben.
Abstract (Originalsprache)
Guillain–Barré syndrome ( GBS ) is frequently accompanied by dysautonomia, which potentially leads to a fatal outcome. Pregabalin binds to the α2δ subunit of voltage‐gated calcium channels and has been used as a drug for neuropathic pain. We present a 47‐year‐old woman who had GBS with severe dysautonomia and painful dysesthesia, in whom pregabalin promptly attenuated both symptoms. After symptoms of respiratory infection lasting a week, she showed mydriatic pupils, ophthalmoparesis, weakness in four limbs with areflexia, cerebellar ataxia and limb dysesthesia. Even after intravenous immunoglobulin therapy was started, her neurological symptoms deteriorated; furthermore, she developed severe dysautonomia including intractable hypertension, bradycardia–tachycardia syndrome, paroxysmal facial flushing and paroxysmal nausea. However, promptly after the first dose of pregabalin, both dysautonomia and dysesthesia were attenuated, and her circulatory condition became stable. Thereafter, her neurological symptoms gradually improved. The present case report suggests that pregabalin can be effective in treating dysautonomia, as well as painful dysesthesia in GBS .
Zitieren
APA
Kuroda, H., Fujihara, K., Nakashima, I., Tateyama, M., Kaneko, K., Tano, O., Kusunoki, S., & Aoki, M. (2013). Pregabalin attenuates dysautonomia as well as painful dysesthesia caused by Guillain–Barré syndrome. Clinical and Experimental Neuroimmunology. https://doi.org/10.1111/cen3.12006
Vancouver
Kuroda H, Fujihara K, Nakashima I, Tateyama M, Kaneko K, Tano O, et al. Pregabalin attenuates dysautonomia as well as painful dysesthesia caused by Guillain–Barré syndrome. Clinical and Experimental Neuroimmunology. 2013. doi:10.1111/cen3.12006
BibTeX
@article{Kuroda2013,
author = {Kuroda, Hiroshi and Fujihara, Kazuo and Nakashima, Ichiro and Tateyama, Maki and Kaneko, Kimihiko and Tano, Ohito and Kusunoki, Susumu and Aoki, Masashi},
title = {Pregabalin attenuates dysautonomia as well as painful dysesthesia caused by Guillain–Barré syndrome},
journal = {Clinical and Experimental Neuroimmunology},
year = {2013},
doi = {10.1111/cen3.12006}
}
EUVIMED